ISRCTN58905233已完成未知
Apolipoprotein B and low density lipoprotein size in type two diabetes: effect of atorvastatin and gemfibrozil
Hospital Sant Pau (Spain)0 个研究点目标入组 44 人开始时间: 2007年4月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 44
研究概览
简要总结
2003 Results article in http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=12843167
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Men and women with type two diabetes, aged 35 to 75 years
- •2. No treatment known to interfere with lipid metabolism (nonselective B-blockers, high dose diuretics, systemic steroids, lipid-lowering drugs) in the month preceding inclusion in the study
- •3. Plasma Low Density Lipoprotein cholesterol (LDLc) greater than 100 mg/dl (2.6 mmol/litre), and triglycerides less than 400 mg/dl (4.51mmol/litre)
排除标准
- •1. Pregnant
- •2. No reliable contraceptive method was used
- •3. Serum creatinine more than 1.7 mg/dl (150 umol/litre)
- •4. Hepatic dysfunction (transaminases greater than 1.5 times upper normal limit at inclusion)
- •5. Creatine kinase more than three times the upper normal limit
- •6. Acute or chronic disorders that might interfere with compliance
研究者
相似试验
已完成
不适用
Mechanisms of Low Levels of Apolipoprotein BCardiovascular DiseasesHeart DiseasesHypobetalipoproteinemiaNCT00005565National Heart, Lung, and Blood Institute (NHLBI)
已完成
不适用
Prospective Russian Evaluation of Lp(a) Role in cardiovascUlar DiseasECoronary DiseaseCardiovascular DiseasesNCT02515747Russian Cardiology Research and Production Center1,400
Unknown
不适用
DARK STUDY "DysbetalipoproteinemiA and atheRoma Risk"DysbetalipoproteinemiaNCT01760265Hospices Civils de Lyon50
已完成
不适用
Intensive LOwering of BlOod low-density lipoprotein ChOlesterol with statin + ezetimibe therapy improves cardiac function after Percutaneous coronary intervention in patients with coronary stenting in Fukuoka-II (LOBOCOP-II)Ischemic heart diseaseJPRN-UMIN000001782Heart/vascular internal medicine,fukuoka university200
Unknown
不适用
Small Dense Low-density Lipoprotein in Patients With Prediabetes and Type 2 DiabetesPrediabetes / Type 2 DiabetesNCT01584856University of Zurich60
